Published in Clin Vaccine Immunol on July 21, 2010
Multiplex detection of plant pathogens using a microsphere immunoassay technology. PLoS One (2013) 0.86
Evaluation of up-converting phosphor technology-based lateral flow strips for rapid detection of Bacillus anthracis Spore, Brucella spp., and Yersinia pestis. PLoS One (2014) 0.86
Identification of an African Bacillus anthracis lineage that lacks expression of the spore surface-associated anthrose-containing oligosaccharide. J Bacteriol (2011) 0.85
Fast and sensitive detection of Bacillus anthracis spores by immunoassay. Appl Environ Microbiol (2012) 0.84
Same-day detection of Escherichia coli O157:H7 from spinach by using electrochemiluminescent and cytometric bead array biosensors. Appl Environ Microbiol (2010) 0.83
Phage display-derived binders able to distinguish Listeria monocytogenes from other Listeria species. PLoS One (2013) 0.79
Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species. BMC Microbiol (2015) 0.79
Identification and characterization of glycoproteins on the spore surface of Clostridium difficile. J Bacteriol (2014) 0.79
Glycosylation of BclA Glycoprotein from Bacillus cereus and Bacillus anthracis Exosporium Is Domain-specific. J Biol Chem (2016) 0.77
De novo asymmetric synthesis of oligo-rhamno di- and tri-saccharides related to the anthrax tetrasaccharide. Tetrahedron (2013) 0.75
Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis--one species on the basis of genetic evidence. Appl Environ Microbiol (2000) 7.87
Novel oligosaccharide side chains of the collagen-like region of BclA, the major glycoprotein of the Bacillus anthracis exosporium. J Biol Chem (2004) 1.92
Cytology of Bacillus anthracis. Fed Proc (1967) 1.80
Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale. Vet J (2005) 1.53
Total synthesis of antigen bacillus anthracis tetrasaccharide--creation of an anthrax vaccine candidate. Angew Chem Int Ed Engl (2005) 1.36
De novo asymmetric synthesis of the anthrax tetrasaccharide by a palladium-catalyzed glycosylation reaction. Angew Chem Int Ed Engl (2007) 1.31
Bacillus spore inactivation methods affect detection assays. Appl Environ Microbiol (2001) 1.28
Anti-carbohydrate antibodies for the detection of anthrax spores. Angew Chem Int Ed Engl (2006) 1.19
Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium. Chemistry (2006) 1.15
Anthrose biosynthetic operon of Bacillus anthracis. J Bacteriol (2008) 1.14
Immunoassay of infectious agents. Biotechniques (2003) 1.00
Performance assessment of three commercial assays for direct detection of Bacillus anthracis spores. J Clin Microbiol (2003) 1.00
Immunogens related to the synthetic tetrasaccharide side chain of the Bacillus anthracis exosporium. Bioorg Med Chem (2007) 0.99
Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cgamma1 heavy of Ckappa light chain gene segments. J Immunol Methods (1998) 0.97
Synthesis of the antigenic tetrasaccharide side chain from the major glycoprotein of Bacillus anthracis exosporium. J Org Chem (2007) 0.96
Studies toward a conjugate vaccine for anthrax. Synthesis and characterization of anthrose [4,6-dideoxy-4-(3-hydroxy-3-methylbutanamido)-2-O-methyl-D-glucopyranose] and its methyl glycosides. Carbohydr Res (2005) 0.95
Synthesis of the tetrasaccharide side chain of the major glycoprotein of the Bacillus anthracis exosporium. Bioorg Med Chem Lett (2005) 0.94
Immuno-detection of anthrose containing tetrasaccharide in the exosporium of Bacillus anthracis and Bacillus cereus strains. J Appl Microbiol (2009) 0.93
Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component. Proc Natl Acad Sci U S A (2008) 0.92
Development of antibodies against anthrose tetrasaccharide for specific detection of Bacillus anthracis spores. Clin Vaccine Immunol (2009) 0.91
Evaluation of the rapid analyte measurement platform (RAMP) for the detection of Bacillus anthracis at a crime scene. Forensic Sci Int (2006) 0.90
Synthesis of the beta anomer of the spacer-equipped tetrasaccharide side chain of the major glycoprotein of the Bacillus anthracis exosporium. Carbohydr Res (2005) 0.87
Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PLoS Med (2005) 4.00
An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis (2005) 3.25
A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. J Biol Chem (2003) 2.84
Exploring the structural diversity of mammalian carbohydrates ("glycospace") by statistical databank analysis. ACS Chem Biol (2007) 2.42
Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis (2002) 2.40
Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature (2002) 2.31
Buruli ulcer disease in Cameroon rediscovered. Am J Trop Med Hyg (2004) 2.29
Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions. Chem Biol (2004) 2.22
Natural Sphingomonas glycolipids vary greatly in their ability to activate natural killer T cells. Chem Biol (2008) 1.95
The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens. Chem Biol (2004) 1.91
Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers. Chem Biol (2007) 1.89
Continuous-flow synthesis of the anti-malaria drug artemisinin. Angew Chem Int Ed Engl (2012) 1.85
Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin. Clin Infect Dis (2011) 1.81
Structures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharides. J Biol Chem (2002) 1.71
Synthetic GPI array to study antitoxic malaria response. Nat Chem Biol (2008) 1.67
On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer. BMC Genomics (2012) 1.58
Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana. PLoS Med (2007) 1.56
Microreactors as tools for synthetic chemists-the chemists' round-bottomed flask of the 21st century? Chemistry (2006) 1.56
Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions. Chemistry (2006) 1.54
Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection? PLoS Negl Trop Dis (2011) 1.51
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial. PLoS One (2008) 1.51
Diagnosis of Mycobacterium ulcerans infection (Buruli ulcer) at a treatment centre in Ghana: a retrospective analysis of laboratory results of clinically diagnosed cases. Trop Med Int Health (2008) 1.44
Genetic diversity in Mycobacterium ulcerans isolates from Ghana revealed by a newly identified locus containing a variable number of tandem repeats. J Bacteriol (2006) 1.44
Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis (2008) 1.43
Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the Mapé Basin of Cameroon. PLoS Negl Trop Dis (2013) 1.42
Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin. PLoS Negl Trop Dis (2007) 1.40
Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans. Chem Biol (2005) 1.39
Evolution of two distinct phylogenetic lineages of the emerging human pathogen Mycobacterium ulcerans. BMC Evol Biol (2007) 1.39
Profiling heparin-chemokine interactions using synthetic tools. ACS Chem Biol (2007) 1.38
Probing protein-carbohydrate interactions with microarrays of synthetic oligosaccharides. Chembiochem (2004) 1.38
Single nucleotide polymorphism typing of Mycobacterium ulcerans reveals focal transmission of buruli ulcer in a highly endemic region of Ghana. PLoS Negl Trop Dis (2010) 1.37
Evaluation of decontamination methods and growth media for primary isolation of Mycobacterium ulcerans from surgical specimens. J Clin Microbiol (2004) 1.36
Total synthesis of antigen bacillus anthracis tetrasaccharide--creation of an anthrax vaccine candidate. Angew Chem Int Ed Engl (2005) 1.36
Microarrays of synthetic heparin oligosaccharides. J Am Chem Soc (2006) 1.35
Genomic diversity and evolution of Mycobacterium ulcerans revealed by next-generation sequencing. PLoS Pathog (2009) 1.33
Tools for glycomics: mapping interactions of carbohydrates in biological systems. Chembiochem (2004) 1.32
Multisite and multivalent binding between cyanovirin-N and branched oligomannosides: calorimetric and NMR characterization. Chem Biol (2002) 1.32
Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana. PLoS One (2011) 1.31
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt. Vaccine (2012) 1.30
Modular synthesis of heparin oligosaccharides. Chemistry (2003) 1.30
The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes. Mol Microbiol (2006) 1.28
Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J Proteome Res (2009) 1.27
Optimized method for preparation of DNA from pathogenic and environmental mycobacteria. Appl Environ Microbiol (2008) 1.27
Use of the immunodominant 18-kiloDalton small heat shock protein as a serological marker for exposure to Mycobacterium ulcerans. Clin Vaccine Immunol (2006) 1.26
Asymmetric reactions in continuous flow. Beilstein J Org Chem (2009) 1.23
Caenorhabditis elegans N-glycan core beta-galactoside confers sensitivity towards nematotoxic fungal galectin CGL2. PLoS Pathog (2010) 1.23
Automated synthesis of the tumor-associated carbohydrate antigens Gb-3 and Globo-H: incorporation of alpha-galactosidic linkages. J Am Chem Soc (2007) 1.21
Clonal groupings in serogroup X Neisseria meningitidis. Emerg Infect Dis (2002) 1.20
Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1. Infect Immun (2003) 1.20
Anti-carbohydrate antibodies for the detection of anthrax spores. Angew Chem Int Ed Engl (2006) 1.19
Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer). Expert Opin Biol Ther (2009) 1.18
Contiguous spread of Mycobacterium ulcerans in Buruli ulcer lesions analysed by histopathology and real-time PCR quantification of mycobacterial DNA. J Pathol (2006) 1.18
Multiple modes of binding enhance the affinity of DC-SIGN for high mannose N-linked glycans found on viral glycoproteins. J Biol Chem (2006) 1.17
Glycomics, glycoproteomics and the immune system. Curr Opin Chem Biol (2012) 1.17
Ongoing genome reduction in Mycobacterium ulcerans. Emerg Infect Dis (2007) 1.16
Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21. Vaccine (2002) 1.16
Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. J Infect Dis (2007) 1.16
A mannan binding lectin is involved in cell-cell attachment in a toxic strain of Microcystis aeruginosa. Mol Microbiol (2006) 1.16
Combining PCR with microscopy to reduce costs of laboratory diagnosis of Buruli ulcer. Am J Trop Med Hyg (2011) 1.15
Carbohydrate arrays as tools for research and diagnostics. Chem Soc Rev (2008) 1.15
Highly efficient continuous flow reactions using singlet oxygen as a "green" reagent. Org Lett (2011) 1.13
In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots. J Am Chem Soc (2009) 1.12
Emergence of W135 meningococcal meningitis in Ghana. Trop Med Int Health (2005) 1.11
Synthesis of a sialic acid alpha(2-3) galactose building block and its use in a linear synthesis of sialyl Lewis X. Org Lett (2007) 1.10
Oligosaccharide synthesis in microreactors. Org Lett (2007) 1.10
Use of diagnostic microarrays for determination of virulence gene patterns of Escherichia coli K1, a major cause of neonatal meningitis. J Clin Microbiol (2005) 1.10
Carbohydrate arrays as tools for glycomics. Angew Chem Int Ed Engl (2002) 1.10
Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin. PLoS Negl Trop Dis (2013) 1.10
Detection of bacteria with carbohydrate-functionalized fluorescent polymers. J Am Chem Soc (2004) 1.09
Alpha1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol alpha-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth. Glycobiology (2008) 1.09
Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics. PLoS Negl Trop Dis (2010) 1.08
Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans. J Leukoc Biol (2006) 1.08
Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides. J Mass Spectrom (2013) 1.08
Automated solid-phase synthesis of protected oligosaccharides containing beta-mannosidic linkages. Chemistry (2008) 1.07
Expression cloning of cholesterol alpha-glucosyltransferase, a unique enzyme that can be inhibited by natural antibiotic gastric mucin O-glycans, from Helicobacter pylori. Biochem Biophys Res Commun (2006) 1.06
The genome, evolution and diversity of Mycobacterium ulcerans. Infect Genet Evol (2012) 1.06
The N'-terminal domain of glyceraldehyde-3-phosphate dehydrogenase of the apicomplexan Plasmodium falciparum mediates GTPase Rab2-dependent recruitment to membranes. Biol Chem (2003) 1.05
Buruli ulcer disease: prospects for a vaccine. Med Microbiol Immunol (2009) 1.05
Carbohydrates as the next frontier in pharmaceutical research. Chemistry (2005) 1.05
Molecular basis of S-layer glycoprotein glycan biosynthesis in Geobacillus stearothermophilus. J Biol Chem (2008) 1.05
Applying flow chemistry: methods, materials, and multistep synthesis. J Org Chem (2013) 1.05
A randomized placebo-controlled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers. PLoS One (2007) 1.04
Automated solid-phase synthesis of β-mannuronic acid alginates. Angew Chem Int Ed Engl (2012) 1.02
Recognition of mannosylated ligands and influenza A virus by human surfactant protein D: contributions of an extended site and residue 343. Biochemistry (2009) 1.02
Molecular epidemiology and antibiotic susceptibility of livestock Brucella melitensis isolates from Naryn Oblast, Kyrgyzstan. PLoS Negl Trop Dis (2013) 1.02
The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors. J Mol Biol (2007) 1.02
Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue? PLoS Negl Trop Dis (2011) 1.01
Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells. Chembiochem (2008) 1.00
Large sequence polymorphisms unveil the phylogenetic relationship of environmental and pathogenic mycobacteria related to Mycobacterium ulcerans. Appl Environ Microbiol (2009) 1.00
Semisynthesis of a glycosylphosphatidylinositol-anchored prion protein. Angew Chem Int Ed Engl (2008) 1.00
Chemoenzymatic synthesis of differentially protected 3-deoxysugars. Nat Chem (2010) 1.00
Phase change material for thermotherapy of Buruli ulcer: a prospective observational single centre proof-of-principle trial. PLoS Negl Trop Dis (2009) 1.00
Continuous synthesis and purification by direct coupling of a flow reactor with simulated moving-bed chromatography. Angew Chem Int Ed Engl (2012) 0.99
Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children. PLoS One (2011) 0.99
Combined approaches to the synthesis and study of glycoproteins. ACS Chem Biol (2009) 0.99
Applications of synthetic carbohydrates to chemical biology. Curr Opin Chem Biol (2010) 0.99
Local activation of the innate immune system in Buruli ulcer lesions. J Invest Dermatol (2006) 0.99
Rapid synthesis of a glycosylphosphatidylinositol-based malaria vaccine using automated solid-phase oligosaccharide synthesis. J Am Chem Soc (2002) 0.98